Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Stage I or II Micro-invasive Oral Cancer 1Head and Neck Neoplasms 1Dermatitis 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Reference Standards × Clear all
NCT04603911 2025-01-10

RCT Comparing ESPB Solutions in Breast Surgery

Tufts Medical Center

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms

NCT05982197 2023-08-08

Curcumin Gel On Radiation Induced Oral Mucositis

University of Baghdad

Phase NA Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05417529 2022-06-14

PMLOS

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Phase NA Completed
60 enrolled

Stage I or II Micro-invasive Oral Cancer

NCT01762020 2017-03-08

Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Dermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡